drugset / Trial / NCT00202410

Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis

NCT00202410 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The frequency of auto-immune diseases (including multiple sclerosis) is increasing in industrialised countries. According to an hypothesis which is receiving a wide international credit, this may be due to the fact that the populations of these countries are increasingly less exposed to microbes further to the improvement of hygienic conditions and to the use of antibiotics. If exposure to microbes is lacking, also their regulatory function is missed with a consequent possible onset of auto-immune symptoms. For this reason, it is deemed that by exposing the immune system of a patient to an ancient microbe, being complex and important in man evolution, like the Tuberculosis Mycobacterium, it is possible to rebalance the immune system.

Timeline

Start
2001-11
Primary completion
2007-09
Completion
2008-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bacille of Calmette-Guerin Vaccine 0.1 ml Other

Indications